一个EGFR联合放大和De Novo长非编码RNAHELDR通过KAT7驱动的基因程序促进质母细胞瘤恶性
Shi-Yuan Cheng1, Xiaozhou Yu1, Xiao Song1
1Northwestern University.
Research square
|July 18, 2025
概括
一种新的长非编码RNA,HELDR,通过激活KAT7,独立于EGFR,驱动质母细胞瘤 (GBM). 向HELDR或KAT7可以提高抗EGFR治疗对GBM的有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 在染色体外DNA (ecDNA) 中表皮生长因子受体 (EGFR) 放大在质母细胞瘤 (GBM) 中很常见.
- 直接向EGFR在GBM治疗中取得了有限的成功.
- 同增强的非编码RNAs在GBM病原发生中的作用在很大程度上仍未被探索.
研究的目的:
- 在GBM中与EGFR共同增强的新型非编码RNA的识别和特征.
- 阐明在GBM瘤发生过程中发现的lncRNA的功能作用.
- 探索针对这种lncRNA的治疗策略,并与EGFR向治疗结合使用.
主要方法:
- 一种新的质母细胞瘤特异性长非编码RNA (lncRNA),HELDR,在ecDNAs中与EGFR共同增强的特征.
- 研究了HELDR的作用机制,包括它与p300的相互作用及其对KAT7转录的影响.
- 在临床前的GBM模型中评估了针对HELDR或KAT7的治疗潜力.
主要成果:
- 鉴定了HELDR,一种IncRNA,可以独立于EGFR信号传递,促进GBM瘤性.
- 证明HELDR向KAT7促进体招募p300,导致H3K27乙化和KAT7转录的增加.
- 表明,KAT7激活通过特定的组织蛋白修饰 (H3K14ac,H4K12ac) 驱动GBM恶性瘤.
- 发现向HELDR或KAT7显著提高了抗EGFR治疗在GBM中的疗效.
结论:
- HELDR是EGFR增强型GBM的关键驱动因素,通过KAT7通路运行.
- 向HELDR或KAT7代表了一种有前途的治疗策略,以克服GBM中EGFR向疗法的耐药性.
- 这项研究强调了在癌症治疗策略中研究与瘤基因共同增强的lncRNA的重要性.
关键词:
欧洲农业基金会 (EGFR) 是一个基金.年长的老人 (ELDR)质母细胞瘤 (glioblastoma) 是一个KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7 KAT7在ncRNA中,我们可以更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.9K
相关概念视频
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
